Skip to main content
Clinical Trials/NCT05589350
NCT05589350CompletedNot Applicable

Comparison of the Impact of Saturated Fat From High-fat Yogurt or Low-fat Yogurt and Butter on Cardiometabolic Risk Markers: a Randomized Cross-over Trial

Shahid Beheshti University1 site in 1 country30 target enrollmentStarted: October 15, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Plasma lipid profile

Study Overview

Brief Summary

The goal of this clinical trial is to compare the effect of saturated fat intake from different source on cardiometabolic risk markers in healthy subjects. The main question it aims to answer are:

-Does intake of saturated fat in the form of high-fat yogurt have a different effect on cardiometabolic risk factors than intake of the same amount from butter? In this study, in two periods of 4 weeks, the effect of receiving saturated fat from high-fat yogurt compared to receiving the same amount of saturated fat from butter and low-fat yogurt on the plasma concentration of lipids, cholesterol, insulin, and some inflammatory factors will be studied in healthy subjects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy people who do not use lipid-lowering, blood pressure control or diabetes medications

Exclusion Criteria

  • •Taking supplements of omega-3 fatty acids, or antioxidants

Arms & Interventions

High-fat yogurt

Experimental

Daily consumption of 1-2 servings (based on daily calorie requirement) of high-fat yogurt

Intervention: saturated fat intake (Other)

Low-fat yogurt and butter

Active Comparator

Daily consumption of 1-2 servings of low-fat yogurt along with daily consumption of about 10 grams of animal butter

Intervention: saturated fat intake (Other)

Outcomes

Primary Outcomes

Plasma lipid profile

Time Frame: 4 weeks

Plasma concentrations of cholesterol, high-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, and triglyceride

Secondary Outcomes

  • Glycemic measures(4 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Javad Nasrollahzadeh

Associate Professor

Shahid Beheshti University

Study Sites (1)

Loading locations...

Similar Trials